A Study of Inhaled AZD8630 in Adolescents with Asthma

Trial Identifier: D6830C00005
Sponsor: AstraZeneca
Start Date: June 2025
Primary Completion Date: February 2026
Study Completion Date: February 2026
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
US, CA Bakersfield, CA, US, 93301
US, FL Miami Lakes, FL, US, 33014
US, LA Lafayette, LA, US, 70508
US, NC Raleigh, NC, US, 27607
US, NE Omaha, NE, US, 68134
US, OH Toledo, OH, US, 43617
US, OK Oklahoma City, OK, US, 73120
US, OR Medford, OR, US, 97504
US, SC Spartanburg, SC, US, 29303
US, TX Austin, TX, US, 78759
US, TX Boerne, TX, US, 78006
US, UT Salt Lake City, UT, US, 84107
US, WI Madison, WI, US, 53792